Skip to main content
OpenTrials

Clinical trial condition

Urogenital Diseases

Explore clinical trials studying Urogenital Diseases. Study availability and eligibility vary by location and protocol.

40,124 public trials 6,115 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Diseases trial results

Recruiting

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

NCT06582017

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +54 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer Los Angeles, California, United States
  • Cedars-Sanai Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport, California, United States
View Trial Details
Recruiting

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

NCT07186842

Conditions
Adnexal Diseases, Advanced Solid Cancers, Bile Duct Diseases, +29 more
Locations
  • SCRI at HCA Health One Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Monash Health Clayton, Australia
View all 17 locations
View Trial Details
Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

NCT06855277

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Urology Centers Of Alabama Pc Homewood, Alabama, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Sansum Clinic Santa Barbara, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
View all 95 locations
View Trial Details
Recruiting

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

NCT07660055

Conditions
Bladder Cancer, Breast Cancer, Breast Diseases, +24 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • Novartis Investigative Site Montreal, Quebec, Canada
View Trial Details
Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NCT07227168

Conditions
Cervical Cancer, Colonic Diseases, Colorectal Cancer, +34 more
Locations
  • SCRI Denver Denver, Colorado, United States
  • SCRI FCS Sarasota Sarasota, Florida, United States
  • Mass General Cancer Center Boston, Massachusetts, United States
  • NEXT Austin Austin, Texas, United States
View Trial Details

Related conditions